Cite
HARVARD Citation
Caffo, O. et al. (2014). Potential value of rapid prostate-specific antigen decline in identifying primary resistance to abiraterone acetate and enzalutamide. Future oncology. pp. 985-993. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Caffo, O. et al. (2014). Potential value of rapid prostate-specific antigen decline in identifying primary resistance to abiraterone acetate and enzalutamide. Future oncology. pp. 985-993. [Online].